1. Proteomics progresses in microbial physiology and clinical antimicrobial therapy

   • B. Chen
   • D. Zhang
   • S. Liang

   Review Open access 04 November 2016 Pages: 403 - 413

   

2. MCR: modern colistin resistance

   • I. Caniaux
   • A. van Belkum
   • M. F. Gros

   Review 21 November 2016 Pages: 415 - 420

3. Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries

   • B. Yanat
   • J.-M. Rodríguez-Martínez
   • A. Touati

   Review 26 November 2016 Pages: 421 - 435

   

4. Prevalence of serological response to Borrelia burgdorferi in farmers from eastern and central Poland

   • V. Zając
   • J. Pinkas
   • I. Bojar

   Original Article Open access 31 October 2016 Pages: 437 - 446

   

5. The association between illicit drug use and infectious complications among trauma patients

   • V. Agrawal
   • J. D. Amos

   Original Article 26 October 2016 Pages: 447 - 450

6. Differences in humoral immune response between patients with or without nasal carriage of Staphylococcus aureus

   • H. Ghasemzadeh-Moghaddam
   • W. van Wamel
   • V. K. Neela

   Original Article 04 November 2016 Pages: 451 - 458

   

7. Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial

   • H. Bao
   • Y. Lv
   • Z. Yan

   Original Article Open access 28 October 2016 Pages: 459 - 466

8. Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations

   • T. Feenstra
   • M. S. Thøgersen
   • R. Kain

   Original Article Open access 05 November 2016 Pages: 467 - 478

   

9. Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions

   • M. Zuin
   • C. Caserta
   • P. M. Battezzati

   Original Article 26 October 2016 Pages: 479 - 485

   

10. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

    • A. Rivero-Juarez
    • L. F. Lopez-Cortes
    • on behalf of the HERACLES cohort study team of the Grupo de Estudio de Hepatitis Virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI)

    Original Article Open access 27 October 2016 Pages: 487 - 494

    

11. MALDI-TOF MS meets WGS in a VRE outbreak investigation

    • S. Schlebusch
    • G. R. Price
    • S. J. Van Hal

    Original Article 26 November 2016 Pages: 495 - 499

    

12. Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study

    • S. Arias
    • O. Denis
    • F. Zech

    Original Article 10 November 2016 Pages: 501 - 507

    

13. Paediatric antibiotic prescriptions in primary care in the Alpes-Maritimes area of southeastern France between 2008 and 2013

    • P. Touboul-Lundgren
    • P. Bruno
    • C. Pradier

    Original Article 03 November 2016 Pages: 509 - 516

    

14. Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model

    • X. Wang
    • K. E. Greenwood-Quaintance
    • R. Patel

    Original Article 28 October 2016 Pages: 517 - 522

    

15. Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma

    • A. Fournier
    • P. Voirol
    • Y.-A. Que

    Original Article 04 November 2016 Pages: 523 - 528

    

16. Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults

    • A. Bjarnason
    • M. Lindh
    • M. Gottfredsson

    Original Article Open access 07 November 2016 Pages: 529 - 536

    

17. Patterns and trends of pediatric bloodstream infections: a 7-year surveillance study

    • N. Buetti
    • A. Atkinson
    • the Swiss Centre for Antibiotic resistance (ANRESIS)

    Original Article 24 November 2016 Pages: 537 - 544

    

18. Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

    • A. M. Cornall
    • M. Poljak
    • S. N. Tabrizi

    Original Article 08 November 2016 Pages: 545 - 551

19. High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied

    • H. Woksepp
    • A. Hällgren
    • T. Schön

    Original Article 04 November 2016 Pages: 553 - 563

    

20. Influenza virus infections in patients with malignancies –– characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO)

    • B. Hermann
    • N. Lehners
    • M. von Lilienfeld-Toal

    Original Article Open access 12 November 2016 Pages: 565 - 573

    

21. Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine

    • L. Georgalis
    • A. Mozalevskis
    • M. Garrido-Estepa

    Original Article 14 November 2016 Pages: 575 - 583

    

22. How obesity impacts outcomes of infectious diseases

    • A. Atamna
    • A. Elis
    • J. Bishara

    Original Article 18 November 2016 Pages: 585 - 591

    

23. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)

    • P. Vieira-Baptista
    • G. Donders

    Letter to the Editor 26 December 2016 Pages: 593 - 594

24. Author’s reply to comment on: is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)

    • J. E. Mazo

    Letter to the Editor 17 December 2016 Pages: 595 - 596